Copyright Reports & Markets. All rights reserved.

Global and Japan Zika Virus Vaccines Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Zika Virus Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Zika Virus Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Zika Virus Vaccines Market Size Growth Rate by Type
    • 1.4.2 DNA Vaccine
    • 1.4.3 Inactivated Vaccine
    • 1.4.4 Purified Inactivated Vaccine
    • 1.4.5 Table of Contents
  • 1.5 Market by Application
    • 1.5.1 Global Zika Virus Vaccines Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Academic and Research
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Zika Virus Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Zika Virus Vaccines Revenue 2015-2026
    • 2.1.2 Global Zika Virus Vaccines Sales 2015-2026
  • 2.2 Global Zika Virus Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Zika Virus Vaccines Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Zika Virus Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Zika Virus Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Zika Virus Vaccines Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Zika Virus Vaccines Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Zika Virus Vaccines Revenue Forecast by Region (2021-2026)

3 Global Zika Virus Vaccines Competitor Landscape by Players

  • 3.1 Global Top Zika Virus Vaccines Sales by Manufacturers
    • 3.1.1 Global Zika Virus Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Zika Virus Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Zika Virus Vaccines Manufacturers by Revenue
    • 3.2.1 Global Zika Virus Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Zika Virus Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Zika Virus Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Zika Virus Vaccines Revenue in 2019
    • 3.2.5 Global Zika Virus Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Zika Virus Vaccines Price by Manufacturers
  • 3.4 Global Zika Virus Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Zika Virus Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Zika Virus Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Zika Virus Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Zika Virus Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Zika Virus Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Zika Virus Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Zika Virus Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Zika Virus Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Zika Virus Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Zika Virus Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Zika Virus Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Zika Virus Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Zika Virus Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Zika Virus Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Zika Virus Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Zika Virus Vaccines Price by Application (2015-2020)
  • 5.2 Zika Virus Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Zika Virus Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Zika Virus Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Zika Virus Vaccines Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Zika Virus Vaccines Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Zika Virus Vaccines Sales YoY Growth 2015-2026
    • 6.1.2 Japan Zika Virus Vaccines Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Zika Virus Vaccines Market Share in Global Market 2015-2026
  • 6.2 Japan Zika Virus Vaccines Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Zika Virus Vaccines Players by Sales (2015-2020)
    • 6.2.2 Japan Top Zika Virus Vaccines Players by Revenue (2015-2020)
  • 6.3 Japan Zika Virus Vaccines Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Zika Virus Vaccines Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Zika Virus Vaccines Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Zika Virus Vaccines Price by Type (2015-2020)
  • 6.4 Japan Zika Virus Vaccines Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Zika Virus Vaccines Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Zika Virus Vaccines Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Zika Virus Vaccines Price Forecast by Type (2021-2026)
  • 6.5 Japan Zika Virus Vaccines Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Zika Virus Vaccines Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Zika Virus Vaccines Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Zika Virus Vaccines Price by Application (2015-2020)
  • 6.6 Japan Zika Virus Vaccines Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Zika Virus Vaccines Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Zika Virus Vaccines Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Zika Virus Vaccines Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Zika Virus Vaccines Market Size YoY Growth 2015-2026
  • 7.2 North America Zika Virus Vaccines Market Facts & Figures by Country
    • 7.2.1 North America Zika Virus Vaccines Sales by Country (2015-2020)
    • 7.2.2 North America Zika Virus Vaccines Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Zika Virus Vaccines Market Size YoY Growth 2015-2026
  • 8.2 Europe Zika Virus Vaccines Market Facts & Figures by Country
    • 8.2.1 Europe Zika Virus Vaccines Sales by Country
    • 8.2.2 Europe Zika Virus Vaccines Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Zika Virus Vaccines Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Zika Virus Vaccines Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Zika Virus Vaccines Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Zika Virus Vaccines Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Zika Virus Vaccines Market Size YoY Growth 2015-2026
  • 10.2 Latin America Zika Virus Vaccines Market Facts & Figures by Country
    • 10.2.1 Latin America Zika Virus Vaccines Sales by Country
    • 10.2.2 Latin America Zika Virus Vaccines Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Zika Virus Vaccines Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Zika Virus Vaccines Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Zika Virus Vaccines Sales by Country
    • 11.2.2 Middle East and Africa Zika Virus Vaccines Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 NHI
    • 12.1.1 NHI Corporation Information
    • 12.1.2 NHI Description and Business Overview
    • 12.1.3 NHI Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 NHI Zika Virus Vaccines Products Offered
    • 12.1.5 NHI Recent Development
  • 12.2 Sanofi
    • 12.2.1 Sanofi Corporation Information
    • 12.2.2 Sanofi Description and Business Overview
    • 12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Sanofi Zika Virus Vaccines Products Offered
    • 12.2.5 Sanofi Recent Development
  • 12.3 GSK
    • 12.3.1 GSK Corporation Information
    • 12.3.2 GSK Description and Business Overview
    • 12.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 GSK Zika Virus Vaccines Products Offered
    • 12.3.5 GSK Recent Development
  • 12.4 Bharat.
    • 12.4.1 Bharat. Corporation Information
    • 12.4.2 Bharat. Description and Business Overview
    • 12.4.3 Bharat. Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Bharat. Zika Virus Vaccines Products Offered
    • 12.4.5 Bharat. Recent Development
  • 12.5 Takeda
    • 12.5.1 Takeda Corporation Information
    • 12.5.2 Takeda Description and Business Overview
    • 12.5.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Takeda Zika Virus Vaccines Products Offered
    • 12.5.5 Takeda Recent Development
  • 12.6 Inovio Pharmaceuticals
    • 12.6.1 Inovio Pharmaceuticals Corporation Information
    • 12.6.2 Inovio Pharmaceuticals Description and Business Overview
    • 12.6.3 Inovio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Inovio Pharmaceuticals Zika Virus Vaccines Products Offered
    • 12.6.5 Inovio Pharmaceuticals Recent Development
  • 12.7 GeneOne Life Science Inc
    • 12.7.1 GeneOne Life Science Inc Corporation Information
    • 12.7.2 GeneOne Life Science Inc Description and Business Overview
    • 12.7.3 GeneOne Life Science Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 GeneOne Life Science Inc Zika Virus Vaccines Products Offered
    • 12.7.5 GeneOne Life Science Inc Recent Development
  • 12.8 PaxVax
    • 12.8.1 PaxVax Corporation Information
    • 12.8.2 PaxVax Description and Business Overview
    • 12.8.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 PaxVax Zika Virus Vaccines Products Offered
    • 12.8.5 PaxVax Recent Development
  • 12.9 Gilead Sciences Inc.
    • 12.9.1 Gilead Sciences Inc. Corporation Information
    • 12.9.2 Gilead Sciences Inc. Description and Business Overview
    • 12.9.3 Gilead Sciences Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Gilead Sciences Inc. Zika Virus Vaccines Products Offered
    • 12.9.5 Gilead Sciences Inc. Recent Development
  • 12.10 Intrexon Corp.
    • 12.10.1 Intrexon Corp. Corporation Information
    • 12.10.2 Intrexon Corp. Description and Business Overview
    • 12.10.3 Intrexon Corp. Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Intrexon Corp. Zika Virus Vaccines Products Offered
    • 12.10.5 Intrexon Corp. Recent Development
  • 12.11 NHI
    • 12.11.1 NHI Corporation Information
    • 12.11.2 NHI Description and Business Overview
    • 12.11.3 NHI Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 NHI Zika Virus Vaccines Products Offered
    • 12.11.5 NHI Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Zika Virus Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Zika Virus Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Zika Virus Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Zika Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Zika Virus Vaccines market is segmented into
    DNA Vaccine
    Inactivated Vaccine
    Purified Inactivated Vaccine
    Table of Contents

    Segment by Application, the Zika Virus Vaccines market is segmented into
    Hospitals
    Clinics
    Academic and Research
    Others

    Regional and Country-level Analysis
    The Zika Virus Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Zika Virus Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Zika Virus Vaccines Market Share Analysis
    Zika Virus Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Zika Virus Vaccines business, the date to enter into the Zika Virus Vaccines market, Zika Virus Vaccines product introduction, recent developments, etc.
    The major vendors covered:
    NHI
    Sanofi
    GSK
    Bharat.
    Takeda
    Inovio Pharmaceuticals
    GeneOne Life Science Inc
    PaxVax
    Gilead Sciences Inc.
    Intrexon Corp.
    NewLink Genetics Corp

    Buy now